HeartRhythm

MARCH 10, 2025

Ablation index (AI)-guided pulmonary vein isolation (PVI) has enhanced procedural outcomes for atrial fibrillation (AF).1 1 However, patients with persistent AF present higher recurrence rates due to advanced atrial remodeling,2-3 represented by the left atrial low voltage area (LVA), compared to those with paroxysmal AF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

DAIC

JANUARY 30, 2025

a powerful and advanced mechanical thrombectomy system for the removal of venous thrombus and the treatment of pulmonary embolism (PE), effectively completing Penumbras VTE platform. Innovative Valve Technology Element features the HemoLockValve System, designed to ensure hemostasis through dual-valve engineering. CAT TM 16 catheter.

Technology 52

Technology Anatomy Embolism Innovation 52

DAIC

SEPTEMBER 4, 2024

The pivotal trial will study the Vertex Pulmonary Embolectomy System, which incorporates Jupiter’s Endoportal Control platform technology into an endovascular procedure intended to treat Acute Pulmonary Embolism (PE) with an unprecedented level of control and precision. pivotal study (NCT06576427).

Pulmonary 52

Pulmonary Embolism Technology Anatomy 52

Frontiers in Cardiovascular Medicine

DECEMBER 23, 2024

BackgroundPercutaneous mechanical thrombectomy (PMT) is increasingly used in the treatment of intermediate and high-risk acute pulmonary embolism (PE), and the treatment of high-risk PE with the aid of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has also been reported. The mortality rate was 27.3% during the 90-day follow-up.

Embolism 52

Embolism Pulmonary Cardiac Arrest Biomarkers 52

DAIC

JULY 31, 2024

a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, reported it has submitted a 510(k) for approval of its patented Morph DNA Steerable Introducer Sheath. mtaschetta-millane Wed, 07/31/2024 - 07:00 July 31, 2024 — BioCardia, Inc. ,

Myocardial Infarction 99

Myocardial Infarction Technology Angina Pulmonary 99

Frontiers in Cardiovascular Medicine

MAY 1, 2024

BackgroundCatheter ablation is frequently used to manage recurrent atrial fibrillation (AF) resistant to drug therapy, with pulmonary vein isolation (PVI) as a key tactic. The reconnection of pulmonary veins was discovered primarily in the anterior region of the right superior PV and the superior portion of the left superior PV.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Pulmonary Technology 52

DAIC

JUNE 4, 2024

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment 5. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) 10. Scientists Suggest a New Method for Diagnosing Heart Diseases 6.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Background Percutaneous pulmonary valve implantation (PPVI) has emerged as a less invasive alternative for treating severe pulmonary regurgitation after tetralogy of Fallot (TOF) repair in patients with a native right ventricular outflow tract (RVOT).

Pulmonary 49

Pulmonary Heart Valves Innovation Technology 49

DAIC

JUNE 13, 2024

Xeltis synthetic restorative pulmonary heart valve evolves into a fully functioning, natural heart valve through colonization by the patient’s own tissue. Xeltis’ novel technology has already treated over 100 patients across different clinical trials.

Heart Valves 111

Heart Valves Technology Pulmonary Outcomes 111

DAIC

JULY 17, 2024

a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases announced that the Unites States Patent Office has granted Patent No: 12,036,371 titled “Method of Accessing the Left Atrium with a Multi-Directional Steerable Catheter,” with a patent term that will expire in 2035.

Myocardial Infarction 105

Myocardial Infarction Atrial Fibrillation Technology Angina 105

Journal of the American Heart Association

MARCH 8, 2024

BackgroundIn recent years, self‐expanding technology to treat pulmonary regurgitation in the native right ventricular outflow tract became Food and Drug Administration approved in the United States and is now routinely used. This paves the way for routine use of VR in patient selection for self‐expanding valve technologies.

Pulmonary 45

Pulmonary Technology Congenital Hospital 45

HeartRhythm

AUGUST 21, 2024

No data have been reported on cooling characteristics and the impact of variant pulmonary vein (PV) anatomy on atrial fibrillation (AF) recurrences after POLARx cryoballoon (CB) ablation.

Anatomy 40

Anatomy Atrial Fibrillation Pulmonary Ablation 40

HCPLive

SEPTEMBER 30, 2024

The latest episode of Lungcast explores the evolving field of pulmonary imaging technology and the transformative impact of artificial intelligence.

Technology 59

Technology Pulmonary 59

Frontiers in Cardiovascular Medicine

MAY 12, 2024

BackgroundAcute pulmonary embolism (APE) is a common and potentially fatal cardiovascular disease that can lead to sudden cardiac arrest in severe cases. For patients with concurrent main pulmonary artery embolism and bleeding, balloon pulmonary angioplasty may be an option.

Embolism 40

Embolism Pulmonary Hemorrhage Cardiac Arrest 40

DAIC

JANUARY 31, 2024

A company statement reported that its PFA System is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal (i.e., The FARAPULSE PFA System is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal (i.e.,

Ablation 111

Ablation Atrial Fibrillation Anatomy Pulmonary 111

HeartRhythm

APRIL 30, 2024

Cryoballoon (CB) ablation is the mainstay of single-shot pulmonary vein isolation (PVI). However, these two technologies have not been compared. A radiofrequency balloon (RFB) catheter has recently emerged as an alternative.

Pulmonary 40

Pulmonary Ablation Technology Outcomes 40

DAIC

MARCH 26, 2024

Using a combination of deep learning and machine learning technologies, the company develops AI solutions that automatically detect and prioritize life-threatening conditions within seconds, assess them for severity, and seamlessly notify clinicians. CINA-iPE and CINA-ASPECTS are the latest tools from Avicenna.AI

Embolism 105

Embolism Pulmonary Blood Clot Cancer 105

HeartRhythm

APRIL 30, 2024

Pulsed field ablation (PFA) has recently been introduced as a novel ablation technology for pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF). High rates of acute PVI have been observed based on electrograms of the PFA device only.

Ablation 40

Ablation Pulmonary Atrial Fibrillation Technology 40

HeartRhythm

APRIL 30, 2024

Non-thermal pulsed field ablation (PFA) is an novel technology to perform pulmonary vein isolation (PVI) for atrial fibrillation (AF). Different PFA systems are available, but no comparative data exist.

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Ablation Technology 40

HeartRhythm

APRIL 30, 2024

Pulmonary vein (PV) isolation is the cornerstone of radiofrequency (RF) ablation for atrial fibrillation (AF). Advances in catheter technology, ablation techniques, and ablation lesion metrics have resulted in improved PV isolation durability. PV reconnection is the most common cause of recurrent AF following an ablation procedure.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pulmonary Technology 40

Journal of Cardiovascular Electrophysiology

FEBRUARY 20, 2025

Methods In this study, blood samples were collected from 16 patients before and 24h after pulmonary vein isolation (PVI) via a novel investigational PFA-based technology.

Biomarkers 40

Biomarkers Pulmonary Technology Ablation 40

Journal of Cardiovascular Electrophysiology

MARCH 3, 2024

Abstract Introduction Through systematic scientific rigor, the CLOSE guided workflow was developed and has been shown to improve pulmonary vein isolation durability. However, this technique was developed at a time when using power-controlled ablation catheters with conventional power ranges was the norm.

Ablation 40

Ablation Pulmonary Technology Outcomes 40

Journal of the American Heart Association

MARCH 13, 2025

BackgroundResearch into the gutlung axis links gut microbiota to pulmonary artery hypertension (PAH). Our findings have implications for advancing gut microbiotabased PAH diagnostic technologies and targeted therapies. Journal of the American Heart Association, Ahead of Print.

Pulmonary 40

Pulmonary Hypertension Technology 40

DAIC

JUNE 7, 2024

a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced that the Unites States Patent Office has granted Patent No: 11,986,611 titled “Radial and Transendocardial Delivery Catheter,” with a patent term that will expire in 2036. Peter Altman , BioCardia CEO.

Hospital 111

Hospital Technology Pulmonary Strokes 111

HeartRhythm

APRIL 30, 2024

No single-shot pulsed field ablation (PFA) technology for pulmonary vein (PV) isolation can directly verify tissue contact.

Ablation 40

Ablation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

Besides single-shot PFA devices for pulmonary vein isolation (PVI), point-by-point PFA is also gaining importance due to many possible applications. Pulsed-field ablation (PFA) is becoming increasingly relevant in the field of electrophysiology. Data on the use is sparse, especially for atrial tachycardia (AT).

Tachycardia 40

Tachycardia Ablation Electrophysiology Technology 40

Society of Thoracic Surgeons - Allied Health

APRIL 17, 2024

Webinar Robotic Bronchoscopy - Managing Sub-Centimeter Lung Cancer Tumors Together cgolden Wed, 04/17/2024 - 10:49 May 9, 2024 Webinar Link: Register for Free In part two of the Robotic Thoracic Surgery webinar series, experts will discuss how a collaborative thoracic and pulmonary robotic approach is expanding thoracic oncology.

Cancer 52

Cancer Webinar Allied Health Best Practices 52

DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Cardiothoracic 59

Journal of Cardiothoracic Surgery

JANUARY 22, 2025

Pulmonary vein isolation (PVI) with cryoballoon (CB) ablation technology is widely used to treat drug-resistant atrial fibrillation (AF). During CB ablation, there is a possibility of forming an ice cap of con.

Ablation 40

Ablation Atrial Fibrillation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

Pulsed field ablation (PFA) has recently been introduced as a novel routine ablation technology for paroxysmal atrial fibrillation (AF). It is also used as off-label therapy for persistent AF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

We have employed digital twin technology to perform extra pulmonary vein (PV) ablation in patients with non-paroxysmal atrial fibrillation (AF). We reported that high dominant frequency (DF) site ablation improved rhythm outcomes, but high maximal slope of action potential restitution curve (Smax) site ablation did not.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Background The newly introduced nonthermal pulsed field ablation (PFA) is a promising technology to achieve fast pulmonary vein isolation (PVI) with high acute success rates and good safety features. PFA versus VHPSD for PVI.

Ablation 40

Ablation Pulmonary Arrhythmia Atrial Fibrillation 40

HeartRhythm

APRIL 30, 2024

Omnipolar mapping technology (OT) uses both unipolar and bipolar signals to obtain omnipolar signals, directions, and speeds. OT Near Field (NF) is a new software (EnSiteXTM, Abbott, St. Paul, MN, USA) which can analyze frequencies to distinguish between NF and far field (FF) potentials.

Atrial Fibrillation 40

Atrial Fibrillation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

Pulsed-field ablation (PFA) is novel ablative technology utilizing high-voltage, ultra-short electrical pulses to induce electroporation and cell apoptosis. The PFA dose needed to induce chronic lesion formation requires further assessment.

Ablation 40

Ablation Technology Pulmonary 40

DAIC

MARCH 20, 2024

He previously served on the AdvaMed Accel Board of Directors and as an observer on the Membership, Ethics and Technology and Regulatory committees of the AdvaMed Board. Billion by 2030 PECA Labs Achieves Successful First-In-Human Implant of the MASA Valve Pediatric Pulmonary Valved Conduit in U.S.

Pediatrics 105

Pediatrics Anatomy Technology Innovation 105

American College of Cardiology

JUNE 28, 2024

Here are my takeaways for what's likely to affect practice in the short and medium-term.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Embolism Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

The 1st generation HeartLight laser balloon (LB) ablation is highly effective in achieving pulmonary vein isolation (PVI), and the safety and 12-month efficacy are comparable with paroxysmal atrial fibrillation (PAF) ablation technologies.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40